Voyager Therapeutics (VYGR) Common Equity (2014 - 2026)
Voyager Therapeutics (VYGR) recorded Common Equity of $154.38 million in Q2 2026, down 36.7% from $243.94 million a year earlier and down 11.1% from the prior quarter.
Voyager Therapeutics (VYGR) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Voyager Therapeutics reported Common Equity of $196.08 million, down 34.6% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $299.76 million in FY2024 (+26.8%), $236.32 million in FY2023 (+300.4%), $59.02 million in FY2022 (-37.9%) and $95.06 million in FY2021 (-38.4%).
- The Q2 2026 figure is the lowest quarterly Common Equity since Q4 2022.
- On a year-over-year basis, Common Equity has declined for six consecutive quarters, with an average decline of 9.3% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 300.4% in Q4 2023, against a decline of 47.4% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $173.67 million (Q1 2026), $196.08 million (Q4 2025) and $219.83 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Voyager Therapeutics | 113.78 Mn | -447.29 Mn | - | 135.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 135.11 Mn |
| Jun 30, 2026 | 154.38 Mn |
| Mar 31, 2026 | 173.67 Mn |
| Dec 31, 2025 | 196.08 Mn |
| Sep 30, 2025 | 219.83 Mn |
| Jun 30, 2025 | 243.94 Mn |
| Mar 31, 2025 | 272.70 Mn |
| Dec 31, 2024 | 299.76 Mn |
| Sep 30, 2024 | 330.31 Mn |
| Jun 30, 2024 | 335.42 Mn |
| Mar 31, 2024 | 340.89 Mn |
| Dec 31, 2023 | 236.32 Mn |
| Sep 30, 2023 | 176.22 Mn |
| Jun 30, 2023 | 199.03 Mn |
| Mar 31, 2023 | 216.96 Mn |
| Dec 31, 2022 | 59.02 Mn |
| Sep 30, 2022 | 79.82 Mn |
| Jun 30, 2022 | 60.05 Mn |
| Mar 31, 2022 | 75.93 Mn |
| Dec 31, 2021 | 95.06 Mn |
Voyager Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VYGR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VYGR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VYGR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();